SCHEMBL823209

SCHEMBL823209

Cc1cccc(CCNC(=O)c2ccc3c4c(ccc(C(=O)O)c24)C(=O)N(CCc2cccc(C)c2)C3=O)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
RAB9A P51151 4/20 0.47
POLB P06746 3/20 0.47
NPC1 O15118 3/20 0.47
MAPT P10636 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
GAA P10253 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46
TP53 P04637 1/20 0.46
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA4 P22748 1/20 0.44
CA7 P43166 1/20 0.44
CACNA1G O43497 2/20 0.44
MYC P01106 1/20 0.43
THRB P10828 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL823211 0.92 MEN1 (0.43) MEN1KMT2ARAB9APOLBNPC1
SCHEMBL823207 0.87 THRB (0.49) MEN1KMT2ARAB9APOLBNPC1
SCHEMBL12104600 0.87 THRB (0.47) MEN1KMT2ARAB9APOLBNPC1
SCHEMBL823199 0.86 NPC1 (0.59) MEN1KMT2ARAB9APOLBNPC1
SCHEMBL16352054 0.86 NPC1 (0.59) MEN1KMT2ARAB9APOLBNPC1
SCHEMBL2212466 0.86 NPC1 (0.59) MEN1KMT2ARAB9APOLBNPC1
SCHEMBL822452 0.85 MEN1 (0.45) MEN1KMT2ARAB9APOLBNPC1
SCHEMBL12039531 0.83 POLB (0.49) MEN1KMT2ARAB9APOLBNPC1
SCHEMBL823223 0.82 NPC1 (0.54) MEN1KMT2ARAB9APOLBNPC1
SCHEMBL5576816 0.82 NPC1 (0.54) MEN1KMT2ARAB9APOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8411489-B2 Semiconducting devices and methods of preparing EASTMAN KODAK COMPANY (US) 2013-04-02 US disclosed
US-8314265-B2 Aromatic amic acids or amic esters and compositions EASTMAN KODAK COMPANY (US) 2012-11-20 US disclosed
US-20110269967-A1 AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS BANK OF AMERICA, N.A., AS AGENT 2011-11-03 US disclosed
WO-2011137139-A1 AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS EASTMAN KODAK COMPANY (US) 2011-11-03 WO disclosed
WO-2011137137-A1 SEMICONDUCTING ARTICLES EASTMAN KODAK COMPANY (US) 2011-11-03 WO disclosed
WO-2011137133-A2 SEMICONDUCTING DEVICES AND METHODS OF PREPARING EASTMAN KODAK COMPANY (US) 2011-11-03 WO disclosed
US-20110266523-A1 SEMICONDUCTING DEVICES AND METHODS OF PREPARING BANK OF AMERICA, N.A., AS AGENT 2011-11-03 US disclosed
US-20110269966-A1 SEMICONDUCTING ARTICLES CITICORP NORTH AMERICA, INC., AS AGENT 2011-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269966-A1 SEMICONDUCTING ARTICLES ALAD, PORCN, DDC MEN1 3245/4885KMT2A 2050/4885RAB9A 2482/4885
US-20110269967-A1 AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS DDC, AADAC, MYOC MEN1 1371/4885KMT2A 1249/4885RAB9A 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.